Wednesday, 3rd of August 2016 |
![]() |
![]() |
The Lancet Oncology, Volume 17, No. 7, p868–869, July 2016
Comment
Outcomes for girls without HPV vaccination in Japan
Yusuke Tanaka,
Yutaka UedaPress enter key to Email the author,
Tomomi Egawa-Takata,
Asami Yagi,
Kiyoshi Yoshino,
Tadashi Kimura
Abstract below; full text is available to journal subscribers.
In Japan, HPV vaccinations became available to girls aged 13–16 years with public aid from 2010 and subsequently became routine for those aged 12–16 years from April, 2013. However, in the spring late spring of 2013, the media repeatedly reported adverse events which were attributed to the HPV vaccination (including pain and motor disability) even though it is not exactly known whether these effects were actually caused by the vaccine. The Japanese Ministry of Health, Labour, and Welfare suspended its active recommendation for girls to receive HPV vaccinations in June, 2013.
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
![]() |
39037382 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |